NCT04949737 Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
| NCT ID | NCT04949737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Center of Martinique |
| Condition | Stomach Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 112 participants |
| Start Date | 2025-10-09 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 112 participants in total. It began in 2025-10-09 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.
Eligibility Criteria
Inclusion Criteria: 1. Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer 2. Patient having read the information note and having signed the consent to participate in the study 3. Patient with social security coverage Exclusion Criteria: 1. Refusal to participate 2. Patient who could not answer the questionnaires 3. Patient not affiliated to a social security system 4. Patient not fluent in French 5. Patient under legal protection (legal protection, guardianship, curators, etc.)
Contact & Investigator
Clarisse JOACHIM-CONTARET
PRINCIPAL INVESTIGATOR
CHU Martinique
Frequently Asked Questions
Who can join the NCT04949737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stomach Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04949737 currently recruiting?
Yes, NCT04949737 is actively recruiting participants. Contact the research team at clarisse.joachim@chu-martinique.fr for enrollment information.
Where is the NCT04949737 trial being conducted?
This trial is being conducted at Fort-de-France, Martinique.
Who is sponsoring the NCT04949737 clinical trial?
NCT04949737 is sponsored by University Hospital Center of Martinique. The principal investigator is Clarisse JOACHIM-CONTARET at CHU Martinique. The trial plans to enroll 112 participants.